Ascendis Pharma A/S - ADR (ASND)

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / ADR
Shares outstanding
55,574,229
Number of holders
139
Total 13F shares, excl. options
46,149,738
Shares change
-301,673
Total reported value, excl. options
$6,420,287,137
Value change
-$13,680,500
Put/Call ratio
23%
Number of buys
71
Number of sells
-58
Price
$139.12

Significant Holders of Ascendis Pharma A/S - ADR (ASND) as of Q4 2019

162 filings reported holding ASND - Ascendis Pharma A/S - ADR as of Q4 2019.
Ascendis Pharma A/S - ADR (ASND) has 139 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 46,149,738 shares of 55,574,229 outstanding shares and own 83% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (7,761,296 shares), FMR LLC (4,773,954 shares), RA CAPITAL MANAGEMENT, L.P. (4,185,342 shares), BAKER BROS. ADVISORS LP (3,390,270 shares), ORBIMED ADVISORS LLC (3,343,100 shares), Artisan Partners Limited Partnership (2,156,396 shares), Avoro Capital Advisors LLC (1,865,000 shares), WELLINGTON MANAGEMENT GROUP LLP (1,717,335 shares), EVENTIDE ASSET MANAGEMENT, LLC (1,698,648 shares), and FARALLON CAPITAL MANAGEMENT LLC (1,279,000 shares).
This table shows the top 139 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.